与年龄相关的斑点退化 (AMD):病理生理学,药物向方法,以及纳米治疗的最新发展
Mahendra Singh1, Riyakshi Negi2, Alka2
1Department of Biotechnology, Institute of Biotechnology, School of Life and Applied Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Medicina (Kaunas, Lithuania)
|October 26, 2024
概括
与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因. 这次审查涵盖了AMD.
科学领域:
- 眼科和视觉科学 眼科和视觉科学
- 分子和细胞生物学分子和细胞生物学
- 遗传学和基因组学 遗传学和基因组学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是老年人视力受损的主要原因,其特点是复杂的病理生理学.
- 目前对AMD的解剖学,遗传学和病理生理学进展的理解仍然不完整,需要进一步研究导致的因素.
- 新兴研究强调了视网膜色素表皮缩,德鲁森,脂素积累和AMD发展中的特定基因的作用.
研究的目的:
- 审查与年龄相关的黄斑变性 (AMD) 的发生率,危险因素和病理生理学.
- 探索氧化应激,炎症,补充系统和生物活性脂质在AMD病变和血管生成中的参与.
- 总结当前和新兴的治疗策略,包括用于AMD治疗的药物输送系统.
主要方法:
- 综合文献综述,重点关注与年龄相关的黄斑变性 (AMD).
- 对研究AMD风险因素的分析,包括遗传和分子机制.
- 对眼部应用的治疗干预和药物输送系统的评估.
主要成果:
- 确定了AMD的主要风险因素,包括氧化应激,炎症,补体激活和生物活性脂质.
- 讨论了这些因素在血管生成中的作用,这是AMD进展的关键过程.
- 总结了当前治疗方法的疗效,缺点和输送方法,如抗VEGF疗法,激酶抑制剂和新型纳米配方.
结论:
- 更深入地了解AMD病理生理学,特别是血管生成和炎症,对于开发有效的治疗方法至关重要.
- 生物活性脂质在AMD的发病过程中发挥着重要作用,并代表着潜在的治疗点.
- 先进的药物输送系统,包括纳米配方,为改善AMD治疗结果提供了有希望的策略.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
1.5K
相关概念视频
01:22Drug Delivery: Miscellaneous Routes
329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
01:26Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
01:22Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165